Haemonetics Corporation

Financials

Overview Отчетность Statistics Dividends

Cash from operating activities 108.81 M172.26 M273.06 M181.75 M181.72 M 338.84 M Cash from investing activities 425.44 M86.34 M143.79 M322.39 M161.9 M 74.89 M Cash from financing activities 367.45 M15.75 M100.36 M38.16 M108.82 M -74.49 M Free cash flow 71.77 M72.35 M159.07 M108.86 M134.75 M 308.07 M

Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen Latham in the 1970s. Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas.

HAE

Financials

Haemonetics Corporation

Новости

Haemonetics получила разрешение FDA на систему сбора плазмы

Haemonetics receives FDA clearance for plasma collection system

IXJ ETF: Healthcare Sector Dashboard For February (NYSEARCA:IXJ)

The London Company Small Cap Q4 2025 Performance And Trades

Haemonetics (HAE) International Revenue Performance Explored

Why Haemonetics (HAE) is a Top Value Stock for the Long-Term

Haemonetics (HAE) is a Top-Ranked Growth Stock: Should You Buy?

Haemonetics Q3 Earnings & Revenues Beat, Margins Up, Stock Slips

These Analysts Revise Their Forecasts On Haemonetics After Q3 Earnings - Haemonetics (NYSE:HAE)

Акции Haemonetics сохраняют рейтинг "выше рынка" от Citizens

Haemonetics stock maintains Market Outperform rating at Citizens on strong plasma growth

Baird снижает целевую цену акций Haemonetics до $81